News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
10,632 Results
Type
Article (1721)
Company Profile (2)
Press Release (8909)
Multimedia
Podcasts (6)
Webinars (2)
Section
Business (4384)
Career Advice (67)
Deals (426)
Drug Delivery (8)
Drug Development (2242)
Employer Resources (14)
FDA (450)
Job Trends (466)
News (6881)
Policy (588)
Tag
40 Under 40 (1)
Academia (35)
Accelerated approval (3)
ADA (3)
Allergies (7)
Alliances (952)
ALS (1)
Alzheimer's disease (53)
Antibody-drug conjugate (ADC) (16)
Approvals (480)
Artificial intelligence (21)
ASCO (15)
Autoimmune disease (19)
Automation (2)
Bankruptcy (3)
Best Places to Work (330)
BIO (2)
Biologics (2)
Biosimilars (20)
Biotechnology (2)
Bispecific (1)
Bladder cancer (10)
Brain cancer (5)
Breast cancer (62)
Cancer (258)
Cardiovascular disease (7)
Career advice (63)
CAR-T (2)
CDMO (4)
Cell therapy (17)
Cervical cancer (2)
Clinical research (1950)
Collaboration (64)
Complete response letters (3)
COVID-19 (100)
C-suite (81)
Cystic fibrosis (2)
Data (200)
Dermatology (1)
Diabetes (16)
Diagnostics (104)
Diversity, equity & inclusion (3)
Drug discovery (10)
Drug pricing (6)
Duchenne muscular dystrophy (5)
Earnings (1041)
Editorial (2)
Employer branding (7)
Employer resources (13)
Events (1093)
Executive appointments (60)
Eye disease (1)
FDA (551)
Funding (35)
Generative AI (3)
Gene therapy (13)
GLP-1 (32)
Government (96)
Guidances (2)
Healthcare (159)
Hematology (8)
HIV (2)
Huntington's disease (2)
IgA nephropathy (3)
Immunology and inflammation (13)
Immuno-oncology (4)
Indications (3)
Infectious disease (107)
Inflammatory bowel disease (4)
Inflation Reduction Act (1)
Influenza (7)
Intellectual property (5)
Interviews (13)
IPO (176)
IRA (2)
Job creations (138)
Job search strategy (57)
JPM (1)
Kidney disease (1)
Labor market (5)
Layoffs (44)
Leadership (1)
Legal (104)
Licensing (4)
Liver cancer (10)
Longevity (2)
Lung cancer (31)
Lymphoma (47)
Management (4)
Manufacturing (29)
MASH (1)
Medical device (29)
Medtech (29)
Mergers & acquisitions (253)
Metabolic disorders (35)
mRNA (15)
Multiple sclerosis (24)
Neurodegenerative disease (12)
Neuropsychiatric disorders (1)
Neuroscience (89)
NextGen: Class of 2026 (143)
Non-profit (56)
Now hiring (2)
Obesity (20)
Opinion (25)
Ovarian cancer (3)
Pain (1)
Pancreatic cancer (8)
Parkinson's disease (8)
Patents (9)
Patient recruitment (3)
Patient selection (1)
Peanut (4)
People (2082)
Pharmaceutical (1)
Phase 1 (590)
Phase 2 (722)
Phase 3 (958)
Pipeline (224)
Policy (8)
Postmarket research (81)
Preclinical (136)
Press Release (1)
Prostate cancer (3)
Psychedelics (1)
Radiopharmaceuticals (4)
Rare diseases (20)
Real estate (75)
Recruiting (5)
Regulatory (545)
Reports (3)
Research institute (37)
Resumes & cover letters (5)
RSV (2)
Series A (7)
Series B (12)
Sickle cell disease (2)
Special edition (2)
Spinal muscular atrophy (45)
Sponsored (1)
Startups (124)
Stomach cancer (3)
Supply chain (1)
Tariffs (1)
The Weekly (6)
Vaccines (30)
Venture capital (5)
Weight loss (9)
Wet AMD (1)
Date
Today (3)
Last 7 days (13)
Last 30 days (53)
Last 365 days (516)
2026 (411)
2025 (465)
2024 (474)
2023 (530)
2022 (832)
2021 (835)
2020 (749)
2019 (787)
2018 (662)
2017 (648)
2016 (508)
2015 (628)
2014 (361)
2013 (251)
2012 (280)
2011 (306)
2010 (253)
Location
Africa (46)
Arizona (11)
Asia (612)
Australia (214)
California (343)
Canada (30)
China (13)
Colorado (4)
Connecticut (1)
Delaware (3)
Europe (1943)
Florida (5)
Illinois (17)
India (1)
Indiana (19)
Japan (4)
Kentucky (3)
Maryland (10)
Massachusetts (121)
Minnesota (2)
Nevada (2)
New Jersey (33)
New York (26)
North Carolina (17)
Northern California (229)
Ohio (2)
Oregon (3)
Pennsylvania (10)
Rhode Island (1)
South America (45)
Southern California (77)
Tennessee (3)
Texas (38)
United States (671)
Utah (10)
Virginia (3)
Washington State (18)
Wisconsin (1)
10,632 Results for "genentech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Artificial intelligence
Genentech makes $1.5B+ deal with AI heavyweight Earendil for cancer bispecifics
Genentech’s agreement with Earendil Labs came the same day its parent company, Roche, inked a cardiometabolic and renal deal with Atavistik Bio for up to $2 billion.
September 25, 2026
·
2 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
Genentech strikes second Asia deal in a week, betting up to $1B in oncology ADC alliance with DualityBio
Through its DualityBio deal, Roche’s Genentech hopes to create antibody-drug conjugates with payloads that can circumvent growing cancer drug resistance.
August 28, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Ark Clinical Research Joins Genentech’s Advancing Inclusive Research® Site Alliance
September 3, 2026
·
2 min read
Press Releases
Positive Interim Data Shows Genentech’s Sefaxersen Significantly Reduces Proteinuria in People With IgA Nephropathy (IgAN)
September 23, 2026
·
6 min read
Business
Genentech culls 103 jobs, inks $490M-plus biobucks deal with Astex
With the latest round, Roche’s Genentech will have racked up nearly 450 layoffs in California over the last year amid ongoing restructuring. At the same time, the biotech is joining forces with Astex Pharmaceuticals in a deal that could surpass $490 million.
July 6, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Genentech’s Lunsumio-Based Regimen Significantly Improves Progression-Free Survival in Follicular Lymphoma in Phase III CELESTIMO Study
September 17, 2026
·
15 min read
Press Releases
U.S. FDA Grants Priority Review for Genentech’s Enspryng for MOGAD, an Autoimmune Disease With No Approved Treatments
September 10, 2026
·
11 min read
Layoffs
Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years
The staffing changes will focus resources on work that creates the highest impact for patients, according to Genentech. The number of employees affected is unknown, but longtime veteran Vishva Dixit is out.
June 11, 2026
·
1 min read
·
Angela Gabriel
Press Releases
Genentech’s Fenebrutinib Is the First BTK Inhibitor to Receive U.S. FDA Filing Acceptance in Both Relapsing and Primary Progressive Multiple Sclerosis
September 30, 2026
·
13 min read
Press Releases
FDA Approves Genentech’s Tecentriq in Combination With a Fluoropyrimidine and Oxaliplatin for the Adjuvant Treatment of a Certain Type of Stage III Colon Cancer
October 9, 2026
·
16 min read
1 of 1,064
Next
